Bio-X
Showing 1,041-1,060 of 1,162 Results
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Christoph Thaiss
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
-
Avnesh Thakor
Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsInterventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular, percutaneous, endoluminal, and even using device implantation approaches
-
Suzanne Tharin
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsThe long-term goal of my research is the repair of damaged corticospinal circuitry. Therapeutic regeneration strategies will be informed by an understanding both of corticospinal motor neuron (CSMN) development and of events occurring in CSMN in the setting of spinal cord injury. MicroRNAs are small, non-coding RNAs that regulate the expression of “suites” of genes. The work in my lab seeks to identify microRNA controls over CSMN development and over the CSMN response to spinal cord injury.
-
Hawa Racine Thiam
Assistant Professor of Bioengineering and of Microbiology and Immunology
Current Research and Scholarly InterestsOur current work has two branches. Branch #1 is building a quantitative and predictive understanding of how neutrophils initiate and complete NETosis. Branch #2 is identifying the molecular and biophysical mechanisms that regulate high deformability in neutrophils. These branches converge onto understanding and harnessing the impact of nuclear biophysics on immune cell functions to re-engineer neutrophils for improved health.
-
Robert Tibshirani
Professor of Biomedical Data Science and of Statistics
Current Research and Scholarly InterestsMy research is in applied statistics and biostatistics. I specialize in computer-intensive methods for regression and classification, bootstrap, cross-validation and statistical inference, and signal and image analysis for medical diagnosis.
-
Alice Ting
Professor of Genetics, of Biology and, by courtesy, of Chemistry
Current Research and Scholarly InterestsWe develop chemogenetic and optogenetic technologies for probing and manipulating protein networks, cellular RNA, and the function of mitochondria and the mammalian brain. Our technologies draw from protein engineering, directed evolution, computational design, chemical biology, organic synthesis, microscopy, and genomics.
-
Andreas Tolias
Professor of Ophthalmology
BioAndreas Tolias is a faculty member at Stanford University, where he co-leads the Enigma Project. His research lies at the interface of neuroscience and AI, combining large-scale neuroscience experiments with machine learning to uncover the principles of natural intelligence. By focusing on perceptual inference and decision-making, his lab integrates systems and computational neuroscience with AI to decipher the network-level principles of intelligence. Dr. Tolias’s work aims to reverse-engineer these principles to create AI systems that are smarter, more robust, trustworthy, and efficient, while providing a powerful platform to test brain algorithms under complex natural tasks. He earned his B.A. and M.A. in Natural Sciences from the University of Cambridge, a Ph.D. in Systems and Computational Neuroscience from MIT, and completed postdoctoral training in Neuroscience and Machine Learning at the Max Planck Institute for Biological Cybernetics in Tübingen.
-
Kimberley Tolias
Professor (Research) of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsThe human brain is composed of billions of neurons connected through trillions of synapses that form the neural circuits underlying thought, emotion, learning, memory, and behavior. These synaptic connections are not static - they are continuously shaped and remodeled throughout life in response to experience, a processes critical for learning and memory. When neural circuits fail to develop or function properly, the consequences can be devastating, contributing to conditions ranging from autism spectrum disorder and intellectual disability to chronic pain, depression, schizophrenia, Alzheimer's disease, and cognitive decline.
Research in the Tolias laboratory seeks to understand the fundamental molecular and cellular mechanisms that govern how neural circuits form, adapt, and repair themselves in the mammalian central nervous system (CNS). Our work focuses on how neurons sense signals from their environment and convert them into intracellular signaling pathways that drive synapse formation and remodeling, dendritic and axonal growth, and cell migration. We are also interested in how disruption of these pathways contributes to neurological and neuropsychiatric disease, and whether targeting specific signaling mechanisms can promote recovery following CNS injury or disease.
The laboratory combines mouse genetics with molecular, cellular, biochemical, electrophysiological, genomic, and behavioral approaches to bridge fundamental neuroscience with translational discovery.
Current Research Areas:
- Molecular mechanisms regulating synapse development, neural circuit formation, and synaptic plasticity during learning and memory
- Roles of Rho GTPase signaling pathways in brain development, circuit remodeling, and neurological disease
- Functions of Adhesion-GPCRs in synapse development, dendritic and axonal growth, and neural circuit function
- Mechanisms underlying chronic pain, opioid tolerance, and chronic pain-associated mood and cognitive disorders
- Synaptic and circuit dysfunction following traumatic brain injury, radiotherapy, and other CNS injuries
- Development of new tools to visualize and map synaptic remodeling during learning and disease
- Interactions between the gut microbiome, brain development, neural circuit function, and behavior -
Natalie Torok
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsOur lab is focused on exploring the role of matrix remodeling in disease progression in metabolic dysfunction steatohepatitis (MASH)-related hepatocellular carcinoma and primary sclerosing cholangitis. Our goal is to uncover how biomechanical characteristics of the ECM affect mechano-sensation, and how these pathways could ultimately be targeted. We are also interested in aging and its effects on metabolic pathways in MASH and HCC.
-
Brian Trippe
Assistant Professor of Statistics and, by courtesy, of Computer Science
BioDr. Brian Trippe is an assistant professor at Stanford in the Department of Statistics, with an affiliation in Stanford Data Science.
In his research, Dr. Trippe develops probabilistic machine learning methods to address challenges in biotechnology and medicine. Recently, his focus has been on generative modeling and inference algorithms for protein engineering.
Before joining Stanford, Dr. Trippe was a postdoctoral fellow at Columbia University in the Department of Statistics, and a visiting researcher at the Institute for Protein Design at the University of Washington. -
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Richard Tsien
George D. Smith Professor, Emeritus
Current Research and Scholarly InterestsWe study synaptic communication between brain cells with the goal of understanding neuronal computations and memory mechanisms. Main areas of focus include: presynaptic calcium channels, mechanisms of vesicular fusion and recycling. Modulation of synaptic strength through changes in postsynaptic receptors and dendritic morphology. Signaling that links synaptic activity to nuclear transcription and local protein translation. Techniques include imaging, electrophysiology, molecular biology.
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone, MD, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford School of Medicine. A neuroscientist and psychiatrist, he leads a laboratory focused on uncovering the biological mechanisms of mental illness and developing novel therapies for mood disorders and addiction. His research centers on defining new cell types and evolutionarily conserved neural circuits involved in emotional processing, with the goal of identifying new therapeutic entry points. Using optogenetic, chemogenetic, neuroimaging, and behavioral approaches in mouse models of addiction, his lab investigates vulnerable brain circuitry underlying opioid use disorder. He also works and collaborates with the Depression Research Clinic, participating in academic and industry sponsored clinical trials investigating novel antidepressant therapies.
Clinically, Dr. Tucciarone works in Stanford’s Neuropsychiatry Clinic, where he treats patients with complex presentations at the interface of psychiatry and neurology, with particular interest in functional neurological disorders. He also sees a small cohort of psychotherapy patients in the Individual Psychotherapy Clinic and works shifts on Stanford’s inpatient psychiatry units.
Dr. Tucciarone completed his psychiatry training through Stanford’s Research Residency Track, where he conducted postdoctoral research under the supervision of Drs. Robert Malenka and Alan Schatzberg. During residency, his research examined neural circuits recruited during opioid withdrawal and explored strategies to enhance the anti-suicidal effects of ketamine through μ-opioid receptor partial agonism.
He received his bachelor’s degree in biology and philosophy from Union College, followed by three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke, where he developed MRI-reportable contrast agents to map neuronal connectivity. He then entered the Medical Scientist Training Program (MD/PhD) at Stony Brook University, completing his PhD in neuroscience under the mentorship of Dr. Josh Huang at Cold Spring Harbor Laboratory. His doctoral work used mouse genetic approaches to dissect excitatory and inhibitory cortical circuits, with a focus on chandelier interneurons in the prefrontal cortex.
In addition to his research and clinical work, Dr. Tucciarone is deeply committed to teaching and mentorship. During residency, he helped restructure neuroscience education for trainees and currently teaches introductory lectures on the neuroscience of addiction, PTSD, psychosis, and mood disorders. He leads resident group supervision in introductory psychodynamic psychotherapy and supervises undergraduates, medical students, residents, and clinical fellows in psychiatry clinics. -
Shripad Tuljapurkar
The Dean and Virginia Morrison Professor of Population Studies
Current Research and Scholarly InterestsStochastic dynamics of human and natural populations; prehistoric societies; probability forecasts including sex ratios, mortality, aging and fiscal balance; life history evolution.
-
Minang (Mintu) Turakhia
Current Research and Scholarly InterestsDr. Turakhia has an active clinical research program, with funding from AHA, VA, NIH, the medical device industry, and foundations. His research program aims to improve the treatment of heart rhythm disorders, with an emphasis on atrial fibrillation, by evaluating quality and variation of care, comparative and cost-effectiveness of therapies, and risk prediction. Dr. Turakhia has extensive expertise in using large administrative and claims databases for this work. His TREAT-AF retrospective study of over 500,000 patients with newly-diagnosed AF is the largest known research cohort of AF patients. He has served as study PI or chairman of several prominent single- and multicenter trials in atrial fibrillation, investigational devices for electrophysiology procedures, digital health interventions, and sensor technologies.
His other research interests include technology assessment of new device-based therapies and the impact of changing health policy and reform on the delivery of arrhythmia care. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society. -
Madeleine Udell
Associate Professor of Management Science and Engineering
Current Research and Scholarly InterestsProfessor Udell builds the mathematical and computational foundations needed for
scalable, accessible, and responsible data-driven decisionmaking in high-stakes domains, with impact on challenges in healthcare, finance, marketing, operations, and engineering.
She develops new efficient algorithms to accelerate and automate optimization and data science, and new frameworks that empower users to invoke these algorithms and interpret the resulting decisions. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
PJ Utz
George DeForest Barnett Professor of Medicine
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
-
Tulio Valdez, MD, MSc
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioDr. Tulio A Valdez is a surgeon scientist with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children’s Hospital (2007), Houston and obtained his Master’s in Clinical and Translational Research at the University of Connecticut.
Clinically, Dr. Valdez has an interest in pediatric sleep apnea. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.
Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at the Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure.
Dr. Valdez believes in multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models.